Immunohematology Mesenchymal Stromal Cell-based Therapy: From Research to Clinic.

Authors : Najar M, Krayem M, Meuleman N, Bron D, Hélène B, Lagneaux L
Year : 2018
Journal : Appl Immunohistochem Mol Morphol
Volume : 26(3)
Pages : e26-e43

Immunomodulatory effects of foreskin mesenchymal stromal cells (FSK-MSCs) on natural killer (NK) cells.

Authors : Najar M, Fayyad-Kazan M, Meuleman N, Bron D, Fayyad-Kazan H, Lagneaux L
Year : 2018
Journal : J Cell Physiol
Volume : 233(7)
Pages : 5243-54

Phase I Dose-Escalation Study of the Anti-CD70 Antibody ARGX-110 in Advanced Malignancies.

Authors : Aftimos P, Rolfo C, Rottey S, Offner F, Bron D, Maerevoet M, Soria JC, Moshir M, Dreier T, Van Rompaey L, Michot JM, Silence K, Hultberg A, Gandini D, de Haard H, Ribrag V, Peeters M, Thibault A, Leupin N, Awada A
Year : 2017
Journal : Clin Cancer Res
Volume : 23(21)
Pages : 6411-6420

New therapeutic approaches in cutaneous T-cell lymphomas

Authors : Bron D, Springael C, Maerevoet M, De Vicq M, Kolivras A
Year : 2017
Journal : Belgian J Hematology
Volume : 8
Pages : 102-6

Unmet needs in the scientific approach to older patients with lymphoma.

Authors : Bron D, Aurer I, André MPE, Bonnet C, Caballero D, Falandry C, Kimby E, Soubeyran P, Zucca E, Bosly A, Coiffier B
Year : 2017
Journal : Haematologica
Volume : 102
Pages : 972-975

Mesenchymal Stromal Cells and Toll-Like Receptor Priming: A Critical Review.

Authors : Najar M, Krayem M, Meuleman N, Bron D, Lagneaux L
Year : 2017
Journal : Immune Netw
Volume : 17
Pages : 89-102

Cognitive compensatory processes of older, clinically fit patients with hematologic malignancies undergoing chemotherapy: a longitudinal cohort study.

Authors : Libert Y, Borghgraef C, Beguin Y, Delvaux N, Devos M, Doyen C, Dubruille S, Etienne AM, Liénard A, Merckaert I, Reynaert C, Slachmuylder JL, Straetmans N, Van Den Neste E, Bron D, Razavi D
Year : 2017
Journal : Psychooncology
Volume : 26(12)
Pages : 2086-2093

Data on HO-1 and CD200 protein secretion during T-cells and mesenchymal stromal cells co-cultures.

Authors : Fayyad-Kazan M, Fayyad-Kazan H, Merimi M, Meuleman N, Bron D, Lagneaux L, Najar M
Year : 2017
Journal : Data Brief
Volume : 11
Pages : 442-445

Study of the microRNA expression profile of foreskin derived mesenchymal stromal cells following inflammation priming.

Authors : Fayyad-Kazan H, Fayyad-Kazan M, Badran B, Bron D, Lagneaux L, Najar M
Year : 2017
Journal : J Transl Med
Volume : 15
Pages : 10

A phase III randomized trial comparing Inolimomab vs. usual care in steroid-resistant acute GVHD.

Authors : Socié G, Vigouroux S, Yakoub-Agha I, Bay JO, Fürst S, Bilger K, Suarez F, Michallet M, Bron D, Gard P, Medeghri Z, Lehert P, Lai C, Corn T, Vernant JP
Year : 2017
Journal : Blood
Volume : 129(5)
Pages : 643-9

Rational therapeutic choice for older patients with lymphoma.

Authors : Bron D, Soubeyran P
Year : 2017
Journal : Curr Opin Oncol
Volume : 29
Pages : 322-327

Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma.

Authors : Dreyling M, Morschhauser F, Bouabdallah K, Bron D, Cunningham D, Assouline SE, Verhoef G, Linton K, Thieblemont C, Vitolo U, Hiemeyer F, Giurescu M, Garcia-Vargas J, Gorbatchevsky I, Liu L, Koechert K, Peña C, Neves M, Childs BH, Zinzani PL
Year : 2017
Journal : Ann Oncol
Volume : 28(9)
Pages : 2169-2178

Viral-induced Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplant.

Authors : Dosin G, Aoun F, El Rassy E, Assi T, Lewalle P, Blanc J, Van Velthoven R, Bron D
Year : 2017
Journal : Clin Lymphoma Myeloma Leuk
Volume : 17(7)
Pages : 438-442

Comparison and immunobiological characterization of retinoic acid inducible gene-I-like receptor expression in mesenchymal stromal cells.

Authors : Raicevic G, Najar M, Busser H, Crompot E, Bron D, Toungouz M, Lagneaux L
Year : 2017
Journal : Sci Rep
Volume : 7(1)
Pages : 2896

Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B-cells from apoptosis, enhance their migration and induce gene expression modifications.

Authors : Crompot E, Van Damme M, Pieters K, Vermeersch M, Perez-Morga D, Mineur P, Maerevoet M, Meuleman N, Bron D, Lagneaux L, Stamatopoulos B
Year : 2017
Journal : Haematologica
Volume : 102(9)
Pages : 1594-1604

Reply to M. Lambertini et al.

Authors : Demeestere I, Brice P, Peccatori FA, Kentos A, Dupuis J, Zachee P, Casasnovas RO, Van Den Neste E, Dechene J, De Maertelaer V, Bron D, Englert Y
Year : 2017
Journal : J Clin Oncol
Volume : 35(7)
Pages : 805-6

Improved survival in patients with CALR1 compared to CALR2 mutated primary myelofibrosis: a meta-analysis.

Authors : Kourie HR, Ameye L, Paesmans M, Bron D
Year : 2017
Journal : Br J Haematol
Volume : 179 (5)
Pages : 846-848

Intraocular T-cell Lymphoma: Clinical Presentation, Diagnosis, Treatment, and Outcome.

Authors : Chaput F, Amer R, Baglivo E, Touitou V, Kozyreff A, Bron D, Bodaghi B, LeHoang P, Bergstrom C, Grossniklaus HE, Chan CC, Peer J, Caspers LE
Year : 2017
Journal : Ocul Immunol Inflamm
Volume : 25(5)
Pages : 639-648

Factors associated with self-perceived burden to the primary caregiver in older patients with hematologic malignancies: an exploratory study.

Authors : Libert Y, Borghgraef C, Beguin Y, Delvaux N, Devos M, Doyen C, Dubruille S, Etienne AM, Liénard A, Merckaert I, Reynaert C, Slachmuylder JL, Straetmans N, Neste EV, Bron D, Razavi D
Year : 2017
Journal : Psychooncology
Volume : 26(1)
Pages : 118-24

Onco-haematology geriatry : impact of cognitive disorders.

Authors : Dubruille S, Libert Y, Razavi D, Bron D
Year : 2016
Journal : Belgian J Hematology
Volume : 7
Pages : 180-3